Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Center, Prospective, Open Label, Single-arm Clinical Study of Safety & Feasibility of Using Navigational Bronchoscopy to Perform Interstitial PD Therapy Using Lipiodol® as a Light Deliver and Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung

NCT04753918 is registered in ClinicalTrials.gov with Taoyuan General Hospital as lead sponsor.

NCT NCT04753918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04753918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Center, Prospective, Open Label, Single-arm Clinical Study of Safety & Feasibility of Using Navigational Bronchoscopy to Perform Interstitial PD Therapy Using Lipiodol® as a Light Deliver and Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung
Lead sponsor
Taoyuan General Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2021
Completion date
February 28, 2022
Enrollment
3 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung metastasis, non-small cell lung cancer (nsclc)